Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study-Reference-Cited by-同舟云学术

Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study

Author:

Myers Kenneth A¹^ORCID,Lightfoot Paul¹,Patil Shekhar G²,Cross J Helen³,Scheffer Ingrid E¹^ORCID

Affiliation:

1. Epilepsy Research Centre; Department of Medicine; The University of Melbourne, Austin Health; Heidelberg Victoria Australia

2. Apollo Paediatric Centre; Apollo Hospital; Navi Mumbai India

3. UCL Institute of Child Health & Great Ormond Street Hospital for Children NHS Foundation Trust; London UK

Funder

National Health and Medical Research Council

Citizens United for Research in Epilepsy

Publisher

Wiley

Subject

Neurology (clinical),Developmental Neuroscience,Pediatrics, Perinatology and Child Health

Link

Reference16 articles.

3. Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy;Brigo;Cochrane Database Syst Rev,2013

5. Stiripentol;Chiron;Expert Opin Investig Drugs,2005

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献